Concepedia

Raymond F. Brown

RF

Statistics

Publications

10

Citations

4K

H-Index

10

Active since

1946

Affiliations

Eli Lilly (United States)(Current)

Raymond F. Brown is an author at Eli Lilly (United States) specializing in pharmacology, cell signaling, and life sciences.

Publications per year

1946–1995

10

Publications

10

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

Chris J. Vlahos, William F. Matter, K. Y. Hui et al. · Journal of Biological Chemistry · 1994 · 3.3K citations · Full text

, , +16

The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs

William F. Matter, Raymond F. Brown, Chris J. Vlahos · Biochemical and Biophysical Research Communications · 1992 · 198 citations

, , +7

Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase.

Chris J. Vlahos, William F. Matter, Raymond F. Brown et al. · The Journal of Immunology · 1995 · 174 citations

, , +17

Antagonists of Phosphatidylinositol 3-Kinase Block Activation of Several Novel Protein Kinases in Neutrophils

Jiabing Ding, Chris J. Vlahos, Ruichun Liu et al. · Journal of Biological Chemistry · 1995 · 125 citations · Full text

, , +15

Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries

Raymond F. Kauffman, James S. Bean, Karen M. Zimmerman et al. · Life Sciences · 1991 · 122 citations

, , +11

1–5 of 10